Case study
EMBLA Medical (Össur)
Eyrir became a 25% shareholder in Össur 2004. The company was founded in 1971 as a small prosthetics workshop and grew into a global leader in non-invasive orthopaedics. In 8 years the revenue increased from 124 million to 400million US dollars. This success was driven by strong organic growth and multiple bolt-on acquisitions to strengthen product offering and market access. At the same time the company was delivering high teens EBITDA throughout economic cycles.
EMBLA Medical (Össur)
Eyrir became a 25% shareholder in Össur 2004. The company was founded in 1971 as a small prosthetics workshop and grew into a global leader in non-invasive orthopaedics. In 8 years the revenue increased from 124 million to 400million US dollars. This success was driven by strong organic growth and multiple bolt-on acquisitions to strengthen product offering and market access. At the same time the company was delivering high teens EBITDA throughout economic cycles.
Today, EMBLA Medical is a home to Ossur, a leading global provider of prosthetics and bracing. Embla supports solutions in addition to companies like Fior & Gentz, an innovative developer of neuro orthotics, and College Park, a brand that is a designer and manufacturer of lower limb prosthetics.
